bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide

C204H223N39O37S — CID 162258624

IUPACbis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide
SMILESC=S(C)(=O)C(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CN(C)C1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CN1CC(c2nnc(C3CC(NC(=O)c4cc(-c5ccccc5)no4)C3)o2)C1.CO[C@H](C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.O=C(NC1CC1)c1cc(-c2ccccc2)co1
InChIInChI=1S/C23H27N5O4.2C23H26N4O4.C22H24N4O4.C20H21N5O3.C20H22N4O4S.2C20H22N4O4.C19H20N4O4.C14H13NO2/c1-14(30-13-15-11-28(2)12-15)22-25-26-23(31-22)17-8-18(9-17)24-21(29)20-10-19(27-32-20)16-6-4-3-5-7-16;2*1-14(29-13-15-6-5-7-15)22-25-26-23(30-22)17-10-18(11-17)24-21(28)20-12-19(27-31-20)16-8-3-2-4-9-16;1-13(28-17-8-5-9-17)21-24-25-22(29-21)15-10-16(11-15)23-20(27)19-12-18(26-30-19)14-6-3-2-4-7-14;1-25-10-14(11-25)20-23-22-19(27-20)13-7-15(8-13)21-18(26)17-9-16(24-28-17)12-5-3-2-4-6-12;1-12(29(2,3)26)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;2*1-3-26-12(2)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;1-11(25-2)18-21-22-19(26-18)13-8-14(9-13)20-17(24)16-10-15(23-27-16)12-6-4-3-5-7-12;16-14(15-12-6-7-12)13-8-11(9-17-13)10-4-2-1-3-5-10/h3-7,10,14-15,17-18H,8-9,11-13H2,1-2H3,(H,24,29);2*2-4,8-9,12,14-15,17-18H,5-7,10-11,13H2,1H3,(H,24,28);2-4,6-7,12-13,15-17H,5,8-11H2,1H3,(H,23,27);2-6,9,13-15H,7-8,10-11H2,1H3,(H,21,26);4-8,11-12,14-15H,2,9-10H2,1,3H3,(H,21,25);2*4-8,11-12,14-15H,3,9-10H2,1-2H3,(H,21,25);3-7,10-11,13-14H,8-9H2,1-2H3,(H,20,24);1-5,8-9,12H,6-7H2,(H,15,16)/t;;;;;;;;11-,13?,14?;/m........1./s1
InChIKeyZYXVZEYSWIIBJR-IYCKEHNXSA-N
MW3845.33 g/mol
LogP33.81
Rot. Bonds65

About bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide

bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide (PubChem CID 162258624) has the molecular formula C204H223N39O37S and a molecular weight of 3845.33 g/mol. Its IUPAC name is bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide.

Molecular Properties

Compound Namebis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide
PubChem CID162258624
Molecular FormulaC204H223N39O37S
Molecular Weight3845.33 g/mol
Exact Mass3842.65
IUPAC Namebis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide
SMILESC=S(C)(=O)C(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CN(C)C1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CN1CC(c2nnc(C3CC(NC(=O)c4cc(-c5ccccc5)no4)C3)o2)C1.CO[C@H](C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.O=C(NC1CC1)c1cc(-c2ccccc2)co1
InChIInChI=1S/C23H27N5O4.2C23H26N4O4.C22H24N4O4.C20H21N5O3.C20H22N4O4S.2C20H22N4O4.C19H20N4O4.C14H13NO2/c1-14(30-13-15-11-28(2)12-15)22-25-26-23(31-22)17-8-18(9-17)24-21(29)20-10-19(27-32-20)16-6-4-3-5-7-16;2*1-14(29-13-15-6-5-7-15)22-25-26-23(30-22)17-10-18(11-17)24-21(28)20-12-19(27-31-20)16-8-3-2-4-9-16;1-13(28-17-8-5-9-17)21-24-25-22(29-21)15-10-16(11-15)23-20(27)19-12-18(26-30-19)14-6-3-2-4-7-14;1-25-10-14(11-25)20-23-22-19(27-20)13-7-15(8-13)21-18(26)17-9-16(24-28-17)12-5-3-2-4-6-12;1-12(29(2,3)26)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;2*1-3-26-12(2)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;1-11(25-2)18-21-22-19(26-18)13-8-14(9-13)20-17(24)16-10-15(23-27-16)12-6-4-3-5-7-12;16-14(15-12-6-7-12)13-8-11(9-17-13)10-4-2-1-3-5-10/h3-7,10,14-15,17-18H,8-9,11-13H2,1-2H3,(H,24,29);2*2-4,8-9,12,14-15,17-18H,5-7,10-11,13H2,1H3,(H,24,28);2-4,6-7,12-13,15-17H,5,8-11H2,1H3,(H,23,27);2-6,9,13-15H,7-8,10-11H2,1H3,(H,21,26);4-8,11-12,14-15H,2,9-10H2,1,3H3,(H,21,25);2*4-8,11-12,14-15H,3,9-10H2,1-2H3,(H,21,25);3-7,10-11,13-14H,8-9H2,1-2H3,(H,20,24);1-5,8-9,12H,6-7H2,(H,15,16)/t;;;;;;;;11-,13?,14?;/m........1./s1
InChIKeyZYXVZEYSWIIBJR-IYCKEHNXSA-N
XLogP33.81
TPSA976.85 Ų
H-Bond Donors10
H-Bond Acceptors66
Rotatable Bonds65
Heavy Atoms281
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003845.33
LogP ≤ 533.81
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1066

Analyze bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide?
The IUPAC name of bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide (CID 162258624) is bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide.
What is the SMILES notation for bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide?
The canonical SMILES for bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide is C=S(C)(=O)C(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CCC1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CC(OCC1CN(C)C1)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CCOC(C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.CN1CC(c2nnc(C3CC(NC(=O)c4cc(-c5ccccc5)no4)C3)o2)C1.CO[C@H](C)c1nnc(C2CC(NC(=O)c3cc(-c4ccccc4)no3)C2)o1.O=C(NC1CC1)c1cc(-c2ccccc2)co1.
What is the InChIKey of bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide?
The InChIKey is ZYXVZEYSWIIBJR-IYCKEHNXSA-N. The full InChI is InChI=1S/C23H27N5O4.2C23H26N4O4.C22H24N4O4.C20H21N5O3.C20H22N4O4S.2C20H22N4O4.C19H20N4O4.C14H13NO2/c1-14(30-13-15-11-28(2)12-15)22-25-26-23(31-22)17-8-18(9-17)24-21(29)20-10-19(27-32-20)16-6-4-3-5-7-16;2*1-14(29-13-15-6-5-7-15)22-25-26-23(30-22)17-10-18(11-17)24-21(28)20-12-19(27-31-20)16-8-3-2-4-9-16;1-13(28-17-8-5-9-17)21-24-25-22(29-21)15-10-16(11-15)23-20(27)19-12-18(26-30-19)14-6-3-2-4-7-14;1-25-10-14(11-25)20-23-22-19(27-20)13-7-15(8-13)21-18(26)17-9-16(24-28-17)12-5-3-2-4-6-12;1-12(29(2,3)26)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;2*1-3-26-12(2)19-22-23-20(27-19)14-9-15(10-14)21-18(25)17-11-16(24-28-17)13-7-5-4-6-8-13;1-11(25-2)18-21-22-19(26-18)13-8-14(9-13)20-17(24)16-10-15(23-27-16)12-6-4-3-5-7-12;16-14(15-12-6-7-12)13-8-11(9-17-13)10-4-2-1-3-5-10/h3-7,10,14-15,17-18H,8-9,11-13H2,1-2H3,(H,24,29);2*2-4,8-9,12,14-15,17-18H,5-7,10-11,13H2,1H3,(H,24,28);2-4,6-7,12-13,15-17H,5,8-11H2,1H3,(H,23,27);2-6,9,13-15H,7-8,10-11H2,1H3,(H,21,26);4-8,11-12,14-15H,2,9-10H2,1,3H3,(H,21,25);2*4-8,11-12,14-15H,3,9-10H2,1-2H3,(H,21,25);3-7,10-11,13-14H,8-9H2,1-2H3,(H,20,24);1-5,8-9,12H,6-7H2,(H,15,16)/t;;;;;;;;11-,13?,14?;/m........1./s1.
What are the key properties of bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide?
bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide has a molecular weight of 3845.33 g/mol, XLogP of 33.81, 65 rotatable bonds, 10 hydrogen bond donors, and 66 hydrogen bond acceptors.
Where does this data come from?
All data for bis(N-[3-[5-[1-(cyclobutylmethoxy)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-(1-cyclobutyloxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-cyclopropyl-4-phenylfuran-2-carboxamide;bis(N-[3-[5-(1-ethoxyethyl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide);N-[3-[5-[(1R)-1-methoxyethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-[(1-methylazetidin-3-yl)methoxy]ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-(1-methylazetidin-3-yl)-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide;N-[3-[5-[1-(methyl-methylidene-oxo-λ6-sulfanyl)ethyl]-1,3,4-oxadiazol-2-yl]cyclobutyl]-3-phenyl-1,2-oxazole-5-carboxamide is sourced from PubChem (CID 162258624), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).